Source:http://linkedlifedata.com/resource/pubmed/id/18698172
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2008-8-13
|
pubmed:abstractText |
In this study, we outline the evidence suggesting that defects in the RNA silencing machinery can lead to the prototypic systemic autoimmune disease, systemic lupus erythematosus, and describe the potential for RNA interference to provide novel therapeutic agents.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1531-6963
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
526-31
|
pubmed:meshHeading |
pubmed-meshheading:18698172-Animals,
pubmed-meshheading:18698172-Gene Therapy,
pubmed-meshheading:18698172-Humans,
pubmed-meshheading:18698172-Lupus Erythematosus, Systemic,
pubmed-meshheading:18698172-MicroRNAs,
pubmed-meshheading:18698172-RNA Interference,
pubmed-meshheading:18698172-T-Lymphocytes
|
pubmed:year |
2008
|
pubmed:articleTitle |
SiLEncing SLE: the power and promise of small noncoding RNAs.
|
pubmed:affiliation |
Division of Immunity and Infection, John Curtin School of Medical Research, Australian National University, Canberra, Australia.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|